DSM invests €100 million in R&D facilities in Netherlands

Feike Sijbesma, Managing Board, Chairman and CEO, DSM.

SITTARD, THE NETHERLANDS: Royal DSM will invest €100 million in three new R&D facilities in Delft and Sittard-Geleen, the Netherlands. The investment in Delft concerns a new laboratory for biotechnological research as well as a DSM contribution to the recently formed consortium for the bioprocess pilot facility (BPF) for bio-research. In Sittard-Geleen a new materials sciences research building will be realized on the Chemelot Campus.

The laboratories are expected to open in 2014. Some 700 researchers will be working there on innovative solutions to major global challenges in fields such as energy & climate and food & health. The new R&D building on the Chemelot Campus in Sittard-Geleen will be a major R&D base for DSM Engineering Plastics. The presence on the Chemelot Campus furthermore offers opportunities for open innovation due to the proximity of other companies and research and education institutes.

“One of the strengths of the Netherlands is the close cooperation between companies, universities and government. This should also involve ensuring that the Netherlands remains competitive, because in the longer term manufacturing and R&D will always have to go together. These investments will enable DSM, together with our partners, to develop innovative and sustainable solutions to the major challenges of our time,” said Feike Sijbesma, Managing Board, Chairman and CEO, DSM.

© WOC News